Researchers from the University of Michigan Rogel Cancer Center will attend the American Society for Radiation Oncology (ASTRO) Annual meeting from Sunday, October 21 through Wednesday, October 24. Many of them plan to participate in poster sessions and oral presentations. A schedule is available to make it easy to know who is presenting, when, where and on what topic
Lori J. Pierce, M.D., is among the new members of the National Academy of Medicine of the National Academies, one of the highest honors in the fields of health and medicine. The institute was formerly called the Institute of Medicine.
The University of Michigan Rogel Cancer Center and Aetna announced a collaboration to create an oncology medical home that is designed to improve the care experience for cancer patients. This approach encourages teams of cancer specialists to work together to care for a patient with a cancer diagnosis.
Smoking-related lung cancer rates are expected to drop dramatically over the next 50 years, but lung cancer will continue to be a significant health problem in the United States, says a University of Michigan researcher.
University of Michigan School of Nursing professor and Rogel Cancer Center member, Christopher Friese has been appointed a member of the Governing Board of the Patient-Centered Outcomes Research Institution, part of the US Government Accountability Office.
The University of Michigan School of Public Health will house a new, multi-institutional center focusing on modeling and predicting the impact of tobacco regulation, funded with an $18 million federal grant from the National Institutes of Health and the Food and Drug Administration.
University of Michigan Rogel Cancer Center member Arul Chinnaiyan, M.D., Ph.D. has received an Outstanding Investigator Award from the National Cancer Institute, which provides $6.5 million in funding over seven years. The grant will fund research to create new bioinformatics resources and identify new cancer biomarkers to improve diagnosis and ultimately to develop new targeted therapies.
The Rogel Cancer Center was 15th (tied with Siteman Cancer Center) in the nation for cancer care by US News and World Report "Best Hospitals" rankings for 2018-19, an honor that measures excellence in patient care. Michigan Medicine, the academic medical center of the University of Michigan, also had 10 surgical and medical specialties ranked in the nation’s top 10. The annual rankings placed Michigan Medicine No. 1 in Michigan.
The biggest threat cancer poses happens when it spreads throughout the body -- and when it has spread to the lining of the abdominal cavity it's particularly tricky. Once these advanced cancers have entered that area, they’re notoriously difficult to treat. Surgery alone is rarely successful, and traditional chemotherapy yields limited results, but a treatment called HIPEC offers hope.
Michigan Medicine and the American Australian Asian Adrenal Alliance: International Collaboration to Study Adrenal Disorders
U-M is a leader in benign adrenal disorders which include primary aldosteronism (discovered by U-M endocrinologist Jerome Conn), hypercortisolism, and pheochromocytoma/paraganglioma (excess production of adrenaline). For many years, there has been a desire to bring together a large network of institutions to work collaboratively to study adrenal disorders in a manner unable to be accomplished by single institutions or by using existing large national databases.